{"paper_id":"0ccdb54b-c0cf-4fc2-812c-b0523bf3f730","body_text":"Auszug\nEndometriose ist als Vorhandensein von endometrialem Gewebe (Drüsen und Stroma) außerhalb des Uteruskavums definiert.\nPreview\nUnable to display preview. Download preview PDF.\nSimilar content being viewed by others\nLiteratur\nEbert AD (2003) Endometriose. Walther de Gruyter Verlag, Berlin\nKoninckx PR (2003) Epidemiology of endometriosis. In: Tulandi T, Redwine D (Hrsg) Endometriosis. Advances and controversies. Marcel Dekker New York 1–18\nKennedy S (2003) Genetics and endometriosis. In: Tulandi T, Redwine D (Hrsg.) Endometriosis: Advances and Controversies. Marcel Dekker, New York, Basel, 55–66\nHolt L, Scholes D, Cushing-Hangen K (2005) Spontaneous and induced abortion and endometriosis risk. Eur. J. Obstet. Gynec. Reprod. Biol. 123,(Suppl.1) S6\nD’Hooghe TM, DeBrock S, Hill JA, Meuleman C (2003) Endometriosis and subfertility: Is the relationship resolved? Sem. Reprod. Med. 21: 243–254\nManolopoulos T, Tinneberg HR (2005) Endometriose und Infertilität. Zbl. Gynäkol. 127: 325–328\nBarnhardt DE, Dunesmoor-Su R, Coutifaris C (2002) Effect of endometriosis on in vitro fertilisation. Fert. Steril. 77: 1148–1155\nPractice Committee Am. Soc. Reprod. Med. (2004) Endometriosis and Infertility. Fert. Steril. 82,Suppl.1, S40–S45\nOmland AK, Tanbo T, Dale PO, Alyholm T (1999) Artificial insemination by husband in unexplained infertility associated with peritoneal endometriosis. Human Reprod. 14: 698–703\nHughes EG (1997) The effectiveness of ovulation of peritoneal infertility: a metaanalysis. Human Reprod 12: 1865–1872\nLessey BA (2000) Medical Management of endometriosis and infertility. Fert. Steril. 73: 1089–1096\nDicker D, Goldman JA, Levy T, Feldberg D, Askkenazi J (1992) The impact of long-term gonadotropin-releasing hormone analogue treatment in preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryotransfers. Fert. Steril. 57: 597–612\nNakamura K, Oosawa M, Kondou I, Inagaki S, Shibata H, Narita O, Suganuma N, Tomoda Y (1992) Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis. J. Assist. Reprod. Genet 9: 113–117\nMarcus SF, Edwards RG (1994) High rates of pregnancy after long-term downregulation of women with severe endometriosis. Am. J. Obstet. Gynecol 171: 812–817\nSurrey ES, Silverberg KM, Surrey MW, Schoolcraft WB (2002) Effect of prolonged gonadotropin-releasing hormone against therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fert. Steril. 78: 699–704\nRickes D, Nickel I, Kropf S, Kleinstein J (2002) Increased pregnancy rates under ultralong postoperative therapy with gonadotropin-releasing hormone analogues in patients with endometriosis. Fert. Steril. 78: 757–762\nDonnez J, Chantraine F, Nisolle M (2002 ) The efficacy of medical and surgical treatment of endometriosis-associated Infertility: arguments in favour of a medico-surgical aproach. Hum Reprod Update 8: 89–94\nSteinleitner A, Lambert H, Roy S (1991) Immunmodulation with pentocifilline abrogates macrophage-mediated infertility in an in vivo-model. A paradigmen for a novel approach to the treatment of endometriosis-associated subfertility. Fert. Steril. 55: 26–31\nTaketani Y, Kuo TM, Mizuno M (1992) Comparison of cytokine levels and embryotoxicity in peritoneal fluid in infertile women with treated or untreated endometriosis. Am. J. Obstet. Gynecol. 167: 265–270\nReeve L, Lashen H (2005) Endometriosis affects spermendosalpingeal interactions. Human Reprod. 20: 448–451\nSchindler AE (2004) Gonadotropin-releasing hormone agonist for prevention of postoperative adhesions: an overview. Gynecol. Endocrinol. 19: 51–55\nMettler M (2000) Makrophagen-Wachstumsfaktor (M-CSF), Hypothese zur Ätiologie der Endometriose. In. Endometriose 2000 L. Mettler (Hrsg.) 153–172. PMI-Verlag, Frankfurt\nSchindler AE (2004) Pathophysiology, diagnosis and treatment of endometriosis. Minerva Ginecol. 56, 419–435\nBrosens IA, Brosens JJ (2000) Adenomyosis and endometriosis: Two typical types of ectopic endometrium. In: Mettler L. (Hrsg.) Endometriose 2000. PMI-Verlag, Frankfurt, 105–112\nHarada T, Enatsu A, Mitsunari M, Nagano Y, Ito M, Tsudo T, Taniguchi F, Iwabe T, Tanikawa M, Terakawa N (1999) Role of Cytokines in Progression of Endometriosis. Gynecol Obstet Invest 47(Suppl.1):34–40\nSeli E, Mahutte NG, Beritkanoglu M, Arici A (2003) Immunology of Endometriosis and Immunotherapy. In: Tulandi T, Redwine D (Hrsg) Endometriosis: Advances and Controversies. Marcel Dekker, New York, 99–122\nIwabe T, Harada T, Terakawa N (2002) Role of cytokines in endometriosis-associated infertility. Gynecol. Obstet. Invest. 53Suppl. 1: 19–25\nFuruya K, Murakami M, Makimura N, Matsuda H, Ikou K, Saito K, Kawakami Y, Shibazaki T, Fukui U, Mizumoto Y, Tokuoka S, Nagata I, Kikuchi I (2003) Immunological and endocrinological studies on lymphocyte subpopulation and medical treatment for infertility in patients with endometriosis. Mol. Cell. Endocrinol. 28: 202 195–199\nCalhaz-Jorge C, Costa AP, Santos MC, Palma-Carlos ML (2003) Peritoneal fluid concentrations of intereukin-8 in patients with endometriosis depend on the severity of the disorder and are higher in the luteal phase. Human Reprod. 18: 593–597\nUlukus M, Ulukus EC, Seval Y, Zheng W, Arici A (2005) Expression of interleukin-8 receptors in endometriosis. Human Reprod. 20: 794–801\nArici A, Matailiotakis I, Goumenou A, Koumantakis G, Vassiliadis S, Selam B, Mahutte NG (2003) Increased levels of interleukin-15 in the peritoneal fluid of women with endometriosis: inverse correlation with stage and depth of invasion. Human Reprod. 18: 429–432\nZhang X, Xu H, Lin J, Qian Y, Deng L (2005) Peritoneal fluid concentrations of interleukin-17 correlate with the severity of endometriosis and infertility of this disorder. BJOG 112: 1153–1157\nKalafi H, Artne H, Demir N (2004) Use of CA125 fluctuation during the menstrual cycle as a tool in the clinic and diagnosis of endometriosis: a preliminary report. Eur. J. Obstet. Gynecol. Reprod. Biol. 16: 85–88\nMathur SP (2000) Autoimmunity in endometriosis: relevance to infertility. Am. J. Reprod. Immunol. 44: 89–95\nInagaki J, Sugiura-Ogasawara M, Nomizu M, Nakasuka M, Ikuta K, Suzuki N, Kaihara K, Kobayaski K, Yasuda T, Shoenfeld Y, Aoki K, Matsuura E (2003) An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients. Human Reprod. 18: 544–549\nCunha-Filho JS, gross JL, Lemos NA, Dias EC, Vettori S. Souza CA, Passos EP (2000) Prolactin and growth hormone secretion after thyrotropin releasing hormone infusion and dopamenergic (DA2) blockade in infertile patients with minimal/mild endometriosis. Human Reprod 17: 960–965\nGermayer A, Gludize LC (2003) How does endometriosis cause infertility? In: Tulandi T, Redwine D (eds) Marcel Dekker, New York, 152–165\nHarlow CR, Cahill DJ, Maile LA, Talbot WM, Mears J, Wardle PG, Hull MG (1996 ) Reduced preovulatory granulosa cell steroidogenesis in women with endometriosis. JCEM 81:426–9.\nDeura I, Harada T, Taniguchi F, Iwabe M, Izawa M, Terakawa N (2005) Reduction of estrogen production by interleukin-6 in a human granulosa cell line may have implications for endometriosis-associated infertility. Fert. Steril. 83Suppl.1: 1086–1092\nTummon IS, Maclin VM, Radwanska E, Binor Z, Dmowski WP (1988) Occult ovulatory dysfunction in women with minimal endometriosis or unexplained infertility. Fert. Steril. 50: 716–720\nPittaway DE, Maxon W, Daniell J., Herbert C, Wentz AC (1983) Lutealphase defect in infertility — patients with endometriosis. Fert. Steril. 39: 712–713\nCahill DJ, Wardle PG, Maile LA, Harlow CR, Hule MG (1997) Ovarian dysfunctions in endometriosis associated with unexplained infertility J. Assist. Reprod, Genet. 14: 554–557\nKaya H, Oral B (1999) Effect of ovarian involvement on the frequency of luteinized unruptured follicle in endometriosis. Gynecol. Obstet. Invest 48:123–126.\nSchenken RS, Asch RH, Williams RF, Hodgen GD (1984) Etiology of infertility in monkeys with endometriosis: luteinized unruptured follicles, luteal phase defects, pelvic adhesions and spontaneous abortions. Fert. Steril 41: 122–130\nCheesman KL, Cheesman SD, Chatterton RT jr, Cohen MR (1983) Alterations in progestogen metabolism and luteal function in infertile women with endometriosis. Fert. Steril. 40: 590–595\nBrosens IA, Koninckx PR, Corveleyn PA (1978) A study of plasma progesterone, oestradiol-17 beta, prolactin und LH levels and of the luteal phase appearance of the ovaries in patients with endometriosis and infertility. Br. J. Obstet. Gynaecol. 85: 246–250\nKissler S, Hamscho N, Zangos S, Gatje R, Muller A, Rody A, Dobert N, Menzel C, Grunwald F, Siebzehnrubl E, Kaufmann M (2005) Diminished pregnancy rates in endometriosis due to impaired uterotubal transport assessed by hysterosalpingoscintigraphy. BJOG 112: 1391–1396\nHalis G, Arici A (2004) Endometriosis and inflammation in infertility. Ann. N. Y. Acad, Sci. 1034: 300–315\nKao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor N, Osteen K, Lessey BA, Giudice LC (2003) Expression profiling of endometrium from women with endometriosis reveals candicate genes for Disease-based implantation failure and infertility. Endocrinology 144: 2870–2881\nDogan S, Machicao F, Wallwiener D, Haering H (2004) Association of peroxisome proliferator-activated receptor gamma 2 pr-12-Ala polymorphism with endometriosis. Fert. Steril. 81: 1411–1413\nAkande VA, Hunt LP, Cahill DJ, Jenkins JM (2004) Differences in time to natural conception between women with unexplained infertility and infertile women with minor endometriosis. Hum Reprod 19:96–103\nAl-Azemi M, Bernal AL, Steele J, Gramsbergen I, Barlow D, Kennedy S (2000) Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis. Hum Reprod 15:72–5\nAlbuquerque LE, Saconato H, Maciel MC (2005) Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles. Cochrane Database Syst Rev 2005 25(1): CD002808\nAnaf V, El Nakadi I, Simon P, Englert Y, Peny MO, Fayt I, Noel JC (2000) Sigmoid endometriosis and ovarian stimulation. Hum Reprod 15: 790–794\nArici A, Oral E, Bukulmez O, Duleba A, Olive DL, Jones EE (1996) The effects of endometriosis on implantation: results from the Yale University in vitro fertilisation and embryo transfer program. Fertil Steril 65:603–7\nBarnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 2002 77:1148–55\nBiljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL (1998) Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues. J Assist Reprod Genet 15:599–604\nBiljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL (1998) Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 70:1063–9\nBrosens I, Gordts S, Campo R (2002) Surgical management of endometriomas — compromised ovarian function. Fertil Steril 78:206–7\nBühler K (1998) Diagnostik der Endometriose. Aus der Sicht des niedergelassenen Gynäkologen. Endometriose Kongreßheft 98:3–10\nCanis M, Pouly JL, Tamburro S, Mage G, Wattiez A, Bruhat MA (2001) Ovarian response during IVF-embryo transfer cycles after laparoscopic ovarian cystectomy for endometriotic cysts of >3 cm in diameter. Hum Reprod 16:2583–6\nChan LY, So WW, Lao TT (2003) Rapid recurrence of endometrioma after transvaginal ultrasound-guided aspiration. Eur J Obstet Gynecol Reprod Biol 109(2):196–8\nCheck JH, Lurie D, O’Shaughnessy, Dietterich C (1995) Endometriosis: The relationship of endometriosis to endometrial sonographic studies prior to administration of human chorionic gonadotrophin in patients undergoing in-vitro fertilization and embryo transfer. Hum Reprod 10:938–41\nCheck JH (2003) What role does decreased ovarian reserve play in the aetiology of infertility related to endometriosis. Hum Reprod 18:653–4\nChedid S, Camus M, Smitz J, Van Streitergem AC, Devroey P (1995) Endometriosis: Comparison among different ovarian stimulation regimens for assisted reproductive procedures in patients with endometriosis. Hum Reprod 10:2406–11\nDamario MA, Moy F, Moomjy M, Davis OK, Tortoriello D, Rosenwaks Z (1997) Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-a) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates. Fertil Steril 68:1004–10\nDamario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z (1997) Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves invitro fertilization outcome in high responder patients. Hum Reprod 12:2359–65\nDe Mouzon J, Belaisch-Allart J, Cohen J, Dubuisson JB, Guichard A, Parinaud J (1988) Dossier FIVNAT, analyse des resultants 1987 stimulations. Contracept Fertil Sex 16:599–615\nDiaz I, Navarro J, Blasco L, Simón C, Pellicer A, Remohí J (2000) Impact of stage III—IV endometriosis on recipients of sibling oocytes: matched control study. Fertil Steril 74:31–4\nDicker D, Goldman GA, Ashkenazi J, Feldberg D, Voliovitz I Goldman JA (1990) The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVFET therapy of severe endometriosis Hum Reprod 5:418–20\nDicker D, Goldman JA, Levy T, Feldberg D, Ashkenazi J (1992) The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer. Fertil Steril 57:597–600\nDitkoff EC, Sauer MV (1996) A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation. Hum Reprod 11:1035–7\nDmowski WP, Rana N, Michalowska J, Friberg J, Papierniak C, el-Roeiy A (1995) The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril 63:555–62\nDmowski WP, Pry M, Ding J, Rana N (2002) Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilisation-embryo transfer. Fertil Steril 78:750–6\nDonnez J, Wyns C, Nisolle M (2001) Does ovarian surgery for endometriomas impair the ovarian response to gonadotropin? Fertil Steril 76:662–5\nDonnez J (2002) Surgical management of endometriomas — compromised ovarian function? — Reply of the author. Fertil Steril 78:207\nEdwards RG, Marcos S, Macnamee M, Balmaceda JP, Walters DF, Asch R (1991) High fecundity of amenorrhoeic women in embryo-transfer programmes. Lancet 338:292–4\nFabregues F, Balasch J, Creus M, Civico S, Carmona F, Puerto B, Vanrell JA (1998) Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program. Fertil Steril 70:46–51\nFeldberg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Dicker D, Goldman JA (1989) Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy. Fertil Steril 51:42–5\nFisch JD, Sher G (2004) Sclerotherapy with 5% tetracycline is a simple alternative to potentially complex surgical treatment of ovarian endometriomas before in vitro fertilization. Fertil Steril 82:437–41\nGarcia-Velasco JA, Mahutte NG, Corona J, Zúñiga, Gilés J, Arici A, Pellicer A (2004) Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study. Fertil Steril 81:1194–7\nGarrido N, Navarro J, Garcia-Velasco J, Remohi J, Pellicer A, Simon C (2002) The endometrium versus embryonic quality in endometriosis-related infertility. Hum Reprod Update 8:95–103\nGarvey TS, Kazer RR, Milad MP (1999) Severe pelvic adhesions following attempted ultrasound-guided drainage of bilateral ovarian endometriomas. Hum Reprod 14:2748–50\nHemmings R, Francois Bissonnette F, Bouzayen R (1998) Results of laparoscopic treatments of ovarian endometriomas: laparoscopic ovarian fenestration and coagulation. Fertil Sterilt 70:527–9\nHerman A, Ron-El R, Golan A, Nahum H, Soffer Y, Caspi E (1990) Follicle cysts after menstrual versus midluteal administration of gonadotropin-releasing hormone analog in in vitro fertilization. Fertil Steril 53:854–8\nHickman TN (2002) Impact of endometriosis on implantation. Data from the Wilford Hall Medical Center IVF-ET program. J Reprod Med 47:801–8\nJahrbücher des Deutschen IVF Register www.deutschesivf-register.de\nJenkins JM, Anthony FW, Wood P, Rushen D, Masson GM, Thomas E (1993) The development of functional ovarian cysts during pituitary down-regulation. Hum Reprod 8:1623–7\nKarande VC, Pratt DE, Rao R, Rabin S, Gleicher N (1995) The limited value of hysterosalpingography in assessing tubal status and fertility potential. Fertil Steril 63: 1067–71\nKarande VC, Pratt DE, Rao R, Balin M, Gleicher N (1995) Elevated tubal perfusion pressures during selective salpingography are highly suggestive of tubal endometriosis. Fertil Steril 64:1070–3\nKeltz MD, Jones EE, Duleba AJ, Polcz T, Kennedy K, Olive DL (1995) Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome. Fertil Steril 64:568–72\nKim CH, Cho YK, Mok JE (1996) Simplified ultralong protocol of gonadotrophin-releasing hormone agonist for ovulation induction with intrauterine insemination in patients with endometriosis. Hum Reprod 11:398–402\nKim CH, Chae HD, Kang BM, Chang YS, Mok JE (1997) The immunotherapy during in vitro fertilization and embryo transfer cycles in infertile patients with endometriosis. J Obstet Gynaecol Res 23:463–7\nKuivasaari P, Hippeläinnen M, Anttila, Heinonen S ((2005) Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and lifeborn rates. Hum Reprod 20:3130–5\nLedger WL (1999) Endometriosis and infertility: an integrated approach. Int J Gynaecol Obstet 64Suppl1:33–40\nLessey BA (2000) Medical management of endometriosis and infertility. Fertil Steril 73:1089–96\nLeyendecker G, Kunz G, Wildt L, Beil D, Deininger H (1996) Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 11:1542–51\nMahutte NG, Arici A (2002) New advances in the understanding of endometriosis related infertility. J Reprod Immunol 55:73–83\nMarcus SF, Edwards RG (1994) High rates of pregnancy after long-term down-regulation of women with severe endometriosis. Am J Obstet Gynecol 171:812–7\nMehta RH, Anand Kumar TC (1999) Can GnRH agonists act directly on the ovary and contribute to cyst formation? Hum Reprod 15:506–7\nMoon HS, Park SH, Lee JO, Kim KS, Joo BS (2004) Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer. Fertil Steril 82:816–20\nMuzii L, Bianchi, Croce C, Manci N, Panici PB (2002) Laparoscopic excision of ovarian cysts: is the stripping technique a tissue-sparing procedure? Fertil Steril 77:609–14\nNadir Ciray H, Bener F, Karagenc L, Ulug U, Bahceci M (2005) Impact of assisted hatching on ART outcome in women with endometriosis. Hum Reprod 20: 2546–9\nNakamura K, Oosawa M, Kondou I, Inagaki S, Shibata H, Narita O, Suganuma N, Tomoda Y (1992) Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis. J Assist Reprod Genet 9:113–7\nOehninger S, Brzyski RG, Muasher SJ, Acosta AA, Jones GS (1989) In-vitro fertilization and embryo transfer in patients with endometriosis: impact of a gonadotrophin releasing hormone agonist. Hum Reprod 4:541–4\nOmland AK, Tanbo T, Dale PO, Byholm T (1998) Effect of endometriosis on in vitro fertilization. Hum Reprod 13:2602–5\nOmland AK, Byholm T, Fedorcsαk P, Ertzeid G, Oldereid NB, Bjercke S, Tanbo T (2005) Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility. Hum Reprod 722–7\nPabuccu R, Onalan G, Goktolga U, Kucuk T, Orhon E, Ceyhan T (2004) Aspiration of ovarian endometriomata before intracytoplasmatic sperm injection. Fertil Steril 82:705–11\nParinaud J, Cohen K, Oustry P, Perineau M, Monrozies X, Reme JM (1992) Influence of ovarian cysts on the results of in vitro fertilization. Fertil Steril 58:1174–7\nPellicer A, Oliveira N, Ruiz A, Remohi J, Simon C (1995) Exploring the mechanism(s) of endometriosis-related infertility: an analysis of embryo development and implantation in assisted reproduction. Hum Reprod 10Suppl 2:91–7\nPellicer A, Navarro J, Bosch E, Garrido N, Garcia-Velasco JA, Remohi J, Simon C (2001) Endometrial quality in infertile women with endometriosis. Ann NY Acad Sci 943:122–30\nPhilips Z, Barraza-Llorens M, Posnett J (2000) Evaluation of the relative cost-effectiveness of treatments for infertility in the UK. Hum Reprod 15:95–106\nQiao J, Yeung WSB, Yao YQ, Ho PC (1998) The effects of follicular fluid from patients with different indications for IVF treatment on the binding of human spermatozoa to the zona pellucida. Hum Reprod 13:128–31\nQublan HS, Amarin Z, Tahat YA, Smadi AZ, Kilani M (2006) Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact. Hum Reprod 21(3):640–4\nRickes D, Nickel I, Kropf S, Kleinstein J (2002) Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 78:757–62\nSallam HN, Garcia-Velasco JA, Dias S, Arici A (2006) Longterm pituitary downregulation before in vitro fertilization (IVF) for women with endometriosis. The Cochrane Database Syst Rev 25(1):CD004635.pub2\nSomigliana E, Vercellini P, Vigano P, Ragni D, Crosignani PG (2006) Should endometriomata be treated before IVF-ICSI cycles? Hum Reprod update 12:57–64\nSuganuma N, Wakahara Y, Ishida D, Asano M, Kitagawa T, Katsumata Y, Moriwaki T, Furuhashi M (1997) Pretreatment for ovarian endometrial cyst before in vitro fertilization. Gynecol Obstet Invest 2002 54Suppl 1:36–40\nSung L, Mukherjee T, Takeshige T, Bustillo M, Copperman AB (1997) Endometriosis is not detrimental to embryo implantation in oocyte recipients. J Assist Reprod Genet 14(3): 152–156\nSurrey ES, Silverberg KM, Surrey MW, Schoolcraft WB (2002) Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 78:699–704\nSuzuki T, Izumi S, Matsubayashi D, Awaji H, Yoshikata K, Makino T (2005) Impact of ovarian endometrioma on oocytes and pregnancy outcome in in vitro fertilization. Fertil Steril 83:908–13\nTan SL, Maconochie N, Doyle P, Campbell S, Balen A, Bekir J, Brinsden P, Edwards RG, Jacobs HS (1994) Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol 171:513–20\nThe Practice Committee of the American Society for Reproductive Medicine (2004) Endometriosis and infertility. Fertil Steril 81:1441–6\nYanushpolsky EH, Best CL, Jackson KV, Clarke RN, Barbieri RL, Hornstein MD (1998) Effects of endometriomas on oocyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet 15:193–7\nYaron Y, Peyser MR, Samuael D, Amit A, Lessing JB (1994) Infected ovarian cysts secondary to oocyte aspiration for in-vitro fertilization. Hum Reprod 9: 1759–60\nYounis JS, Ezra Y, Laufer N, Ohel G (1997) Late manifestation of pelvic abscess following oocyte retrieval, for in vitro fertilization, in patients with severe endometriosis and ovarian endometriomata. J Assist Reprod Genet 14:343–6\nBarnhart K, Dunsmoor-Su R, Coutifaris C (2002) Effect of endometriosis on in vitro fertilization. Fertil. Steril. 77:1148–1155\nBrosens IA, Cornillie FJ (1987) Peritoneal endometriosis. Morphological basis of the laparoscopic diagnosis. Contr. Gynecol. Obstet. 16:125–131\nCirkel U, Ochs H, Latussek B, Schneider HPG (1991) Aussagekraft der Tumormarker CA 125, CA 19-9, CA 15-3 und CEA bei Endometriose. Geburtsh. u. Frauenheilk. 51:626–631\nDonnez J, Nisolle M, Gillerot S, Anef V, Clerck-Braun F, Casabas-Roux F (1994) Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist. Fertil. Steril. 62:63–66\nGerber S, Paraschos T, Atkinson G (1995) Results of IVF in patients with endometriosis. Hum. Reprod. 10:1507–1511\nKauppila A, Rönnberg L, Vihko R (1986) Steroidrezeptoren in endometriotischem Gewebe. Endometriose 4:56–60\nMarcoux S, Maheux R, Berúbe S and the Canadian Collaborative Group On Endometriosis (1997) Laparoscopic surgery in infertile women with minimal or mild endometriosis. N. Engl. J. Med. 337: 217–222\nOlivennes F, Feldberg D, Liu H-C (1995) Endometriosis: a stage by stage analysis — the role of in vitro fertilisation. Fertil. Steril. 64:392–398\nPalacios SJ (1991) An approach to endometriosis with infertility. Br. J. Clin. Pract. 72: 27–32\nParazzini F (1999) Ablation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomized trial. Hum. Reprod. 14: 1332–1334\nSchweppe K-W (1984) Morphologie und Klinik der Endometriose. FK Schattauer, Stuttgart — New York\nSchweppe K-W, Dmowski WP, Rolland R (1990) Endometriose — Pathophysiologie, Klinik und neue Behandlungsmöglichkeiten. Institut Mensch u. Arbeit, R. Pfützner GmbH: Aktuelles Wissen Hoechst, München\nAuthor information\nAuthors and Affiliations\nRights and permissions\nCopyright information\n© 2007 Springer Medizin Verlag Heidelberg\nAbout this chapter\nCite this chapter\nSchindler, A.E., Bühler, K., Schweppe, K.W. (2007). Zur Bedeutung der Endometriose in der Reproduktionsmedizin. In: Das Deutsche IVF-Register 1996–2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-49928-2_10\nDownload citation\nDOI: https://doi.org/10.1007/978-3-540-49928-2_10\nPublisher Name: Springer, Berlin, Heidelberg\nPrint ISBN: 978-3-540-37324-7\nOnline ISBN: 978-3-540-49928-2\neBook Packages: Medicine (German Language)","source_license":"CC0","license_restricted":false}